Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 183

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Expression and Degradation of Androgen Receptor: Mechanism and Clinical Implication

Lee, Dong Kun, Chang, Chawnshang · 2003 · The Journal of Clinical Endocrinology & Metabolism

Abstract

The androgen-androgen receptor (AR) signaling pathway plays a key role in proper development and function of male reproductive organs, such as prostate and epididymis, as well as nonreproductive organs, such as muscle, hair follicles, and brain. Abnormalities in the androgen-AR signaling pathway have been linked to diseases, such as male infertility, Kennedy’s disease, and prostate cancer. Regulation of AR activity can be achieved in several different ways: modulation of AR gene expression, androgen binding to AR, AR nuclear translocation, AR protein stability, and AR trans-activation. This review covers mechanisms implicated in the control of AR protein expression and degradation, and their potential linkage to the androgen-related diseases. A better understanding of such mechanisms may help us to design more effective androgens and antiandrogens to battle androgen-related diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2003-030261

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 130

  1. Chang, 1988, Molecular cloning of the human and rat complementary DNA encoding androgen receptors., Science, 240, 324, 10.1126/science.3353726 · DOI · Paper page
  2. Lubahn, 1988, Cloning of the human androgen receptor complementary DNA and localization to the X chromosome., Science, 240, 327, 10.1126/science.3353727 · DOI · Paper page
  3. Trapman, 1988, Cloning, structure and expression of a cDNA encoding the human androgen receptor., Biochem Biophys Res Commun, 153, 241, 10.1016/S0006-291X(88)81214-2 · DOI · Paper page
  4. Chang, 1995, Androgen receptor: an overview., Crit Rev Eukaryotic Gene Express, 5, 97, 10.1615/CritRevEukarGeneExpr.v5.i2.10 · DOI · Paper page
  5. Roy, 1999, Regulation of androgen action., Vit Horm, 55, 309, 10.1016/S0083-6729(08)60938-3 · DOI · Paper page
  6. Miller, 1988, Molecular biology of steroid hormone synthesis., Endocr Rev, 9, 295, 10.1210/edrv-9-3-295 · DOI · Paper page
  7. Deslypere, 1992, Testosterone and 5-α-dihydrotestosterone interact differently with the androgen receptor to enhance transcription of the MMTV-CAT reporter gene., Mol Cell Endocrinol, 88, 15, 10.1016/0303-7207(92)90004-P · DOI · Paper page
  8. Quigley, 1995, Androgen receptor defects: historical, clinical, and molecular perspectives., Endocr Rev, 16, 271
  9. Avila, 2001, The androgen receptor (AR) in syndromes of androgen insenstivity and in prostate cancer., J Steroid Biochem Mol Biol, 76, 135, 10.1016/S0960-0760(00)00158-8 · DOI
  10. Migeon, 1981, Studies of the locus for androgen receptor: localization on the human X chromosome and evidence for homology with the Tfm locus in the mouse., Proc Natl Acad Sci USA, 78, 6339, 10.1073/pnas.78.10.6339 · DOI
  11. Brown, 1989, Androgen receptor locus on the human X chromosome: regional localization to Xq11–12 and description of a DNA polymorphism., Am J Hum Genet, 44, 264
  12. Yeh, 2002, Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen function., Proc Natl Acad Sci USA, 99, 13498, 10.1073/pnas.212474399 · DOI · Paper page
  13. Tsai, 1994, Molecular mechanisms of action of steroid/thyroid receptor superfamily members., Annu Rev Biochem, 63, 451, 10.1146/annurev.bi.63.070194.002315 · DOI · Paper page
  14. Edwards, 1999, Androgen receptor polymorphisms: association with prostate cancer risk, relapse, and overall survival., Int J Cancer, 84, 458, 10.1002/(SICI)1097-0215(19991022)84:5<458::AID-IJC2>3.0.CO;2-Y · DOI
  15. Sleddins, 1993, Trinucleotide (GGN) repeat polymorphism in the androgen receptor gene., Hum Mol Genet, 2, 273
  16. Kazemi-Esfarjani, 1995, Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies., Hum Mol Genet, 4, 523, 10.1093/hmg/4.4.523 · DOI · Paper page
  17. Hsiao, 1999, The linkage of Kennedy’s Neuron Disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator., J Biol Chem, 274, 20229, 10.1074/jbc.274.29.20229 · DOI · Paper page
  18. Jenster, 1994, Changes in the abundance of androgen receptor isotypes: effects of ligand treatment, glutamine stretch variation, and mutation of putative phosphorylation sites., Biochemistry, 33, 14064, 10.1021/bi00251a015 · DOI
  19. McPhaul, 1991, Molecular basis of androgen resistance in a family with a qualitative abnormality of the androgen receptor and responsive to high dose androgen therapy., J Clin Invest, 87, 1413, 10.1172/JCI115147 · DOI
  20. Choong, 1996, Reduced androgen receptor gene expression with first exon CAG repeat expansion., Mol Endocrinol, 10, 1527
  21. La Spada, 1991, Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy., Nature, 352, 77, 10.1038/352077a0 · DOI · Paper page
  22. Hakimi, 1997, Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer., Clin Cancer Res, 3, 1599
  23. Gao, 1996, Transcriptional activation and transient expression of the human androgen receptor., J Steroid Biochem Mol Biol, 59, 9, 10.1016/S0960-0760(96)00097-0 · DOI · Paper page
  24. Montgomery, 2001, The androgen receptor gene and its influence on the development and progression of prostate cancer., J Pathol, 195, 138, 10.1002/1096-9896(200109)195:2<138::AID-PATH961>3.0.CO;2-Y · DOI
  25. He, 2000, FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor., J Biol Chem, 275, 22986, 10.1074/jbc.M002807200 · DOI · Paper page
  26. He, 1999, Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH2-terminal domain., J Biol Chem, 274, 37219, 10.1074/jbc.274.52.37219 · DOI · Paper page
  27. Ikonen, 1997, Interaction between the amino and carboxyl terminal regions of rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators., J Biol Chem, 272, 29821, 10.1074/jbc.272.47.29821 · DOI · Paper page
  28. Moilanen, 1999, A testis-specific androgen receptor coregulator that belongs to a novel family of nuclear proteins., J Biol Chem, 274, 3700, 10.1074/jbc.274.6.3700 · DOI
  29. Gioeli, 2002, Androgen receptor phosphorylation: regulation and identificaton of the phosphorylation sites., J Biol Chem, 277, 29304, 10.1074/jbc.M204131200 · DOI · Paper page
  30. Weigel, 1996, Steroid hormone receptors and their regulation by phosphorylation., Biochem J, 319, 657, 10.1042/bj3190657 · DOI · Paper page
  31. Poukka, 2000, Covalent modification of the androgen receptor by small ubiquitin-like modifier 1(SUMO-1)., Proc Natl Acad Sci USA, 97, 14145, 10.1073/pnas.97.26.14145 · DOI · Paper page
  32. Schoenmakers, 1999, Differential DNA binding by the androgen and glucocorticoid receptors involves the second Zn-finger and a C-terminal extension of the DNA binding domain., Biochem J, 341, 515, 10.1042/bj3410515 · DOI · Paper page
  33. Jenster, 1993, Nuclear import of the androgen receptor., Biochem J, 293, 761, 10.1042/bj2930761 · DOI · Paper page
  34. Zhou, 1994, A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor., J Biol Chem, 269, 13115, 10.1016/S0021-9258(17)36806-0 · DOI · Paper page
  35. Sheflin, 2000, Inhibiting proteasomes in human HepG2 and LNCaP cells increases endogenous androgen receptor levels., Biochem Biophys Res Commun, 276, 144, 10.1006/bbrc.2000.3424 · DOI
  36. Rechsteiner, 1996, PEST sequences and regulation by proteolysis., Trends Biochem Sci, 21, 267, 10.1016/S0968-0004(96)10031-1 · DOI · Paper page
  37. Matias, 2000, Structural evidence for ligand specificity in the binding domain of the human androgen receptor., J Biol Chem, 275, 26164, 10.1074/jbc.M004571200 · DOI · Paper page
  38. Sack, 2001, Crystallographic structures of the ligand binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydroxytestosterone., Proc Natl Acad Sci USA, 98, 4904, 10.1073/pnas.081565498 · DOI · Paper page
  39. Williams, 1998, Atomic structure of progesterone complexed with its receptor., Nature, 393, 392, 10.1038/30775 · DOI · Paper page
  40. Bourguet, 2000, Nuclear receptor ligand binding domains: three-dimensional structures, molecular interactions and pharmacological implications., Trends Pharmacol Sci, 21, 381, 10.1016/S0165-6147(00)01548-0 · DOI · Paper page
  41. Nolte, 1998, Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor gamma., Nature, 395, 137, 10.1038/25931 · DOI · Paper page
  42. Darimont, 1998, Structure and specificity of nuclear receptor-coactivator interactions., Genes Dev, 12, 3343, 10.1101/gad.12.21.3343 · DOI · Paper page
  43. McInerney, 1998, Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation., Genes Dev, 12, 3357, 10.1101/gad.12.21.3357 · DOI · Paper page
  44. Bevan, 1999, The AF-1 and AF-2 domains of the androgen receptor interact with distinct regions of SRC1., Mol Cell Biol, 19, 8383, 10.1128/MCB.19.12.8383 · DOI · Paper page
  45. Chang, 2002, Evaluation of ligand-dependent changes in AR structure using peptide probes., Mol Endocrinol, 16, 647, 10.1210/mend.16.4.0818 · DOI
  46. Wilson, 1996, A and B forms of the androgen receptor are expressed in a variety of human tissues., Mol Cell Endocrinol, 120, 51, 10.1016/0303-7207(96)03819-1 · DOI · Paper page
  47. Gao, 1998, Functional activities of the A and B forms of the human androgen receptor in response to androgen receptor agonists and antagonists. Mol., Endcrinol, 12, 654, 10.1210/mend.12.5.0112 · DOI
  48. Conneely, 2001, Reproductive functions of the progesterone receptor isoforms: lessons from knock-out mice., Mol Cell Endocrinol, 179, 97, 10.1016/S0303-7207(01)00465-8 · DOI · Paper page
  49. Trapman, 1990, The androgen receptor: functional structure and expression in transplanted human prostate tumors and prostate tumor cell lines. J., Steroid Biochem Mol Biol, 37, 837, 10.1016/0960-0760(90)90429-O · DOI
  50. Krongrad, 1991, Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cells., Mol Cell Endocrinol, 76, 79, 10.1016/0303-7207(91)90262-Q · DOI · Paper page
  51. Wolf, 1993, Transcriptional and posttranscriptional regulation of human androgen receptor expression by androgen., Mol Endocrinol, 7, 924
  52. Zhou, 1995, Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability., Mol Endocrinol, 9, 208
  53. Wiren, 1997, Transcriptional up-regulation of the human androgen receptor by androgen in bone cells., Endocrinology, 138, 2291, 10.1210/endo.138.6.5163 · DOI
  54. Yu, 1995, Effect of androgens and their manipulation on cell growth and androgen receptor (AR) levels in AR-positive and -negative human hepatocellular carcinomas., J Hepatol, 22, 295, 10.1016/0168-8278(95)80282-7 · DOI
  55. Kerr, 1995, Distribution and hormonal regulation of androgen receptor (AR) and AR messinger ribonucleic acid in the rat hippocampus., Endocrinology, 136, 3213, 10.1210/endo.136.8.7628354 · doi:10.1210/endo.136.8.7628354 · Paper page
  56. Takeda, 1991, Autoreguation of androgen receptor expression in the rodent prostate: immunohistochemical and in situ hybridization analysis., Biochem Biophys Res Commun, 177, 488, 10.1016/0006-291X(91)92010-H · DOI
  57. Quarmby, 1990, Autologous down-regulation of androgen receptor messenger ribonucleic acid., Mol Endocrinol, 4, 22, 10.1210/mend-4-1-22 · DOI · Paper page
  58. Liao, 1965, Influence of testosterone on template activity of prostatic ribonucleic acids., J Biol Chem, 240, 1236, 10.1016/S0021-9258(18)97566-6 · doi:10.1016/s0021-9258(18)97566-6
  59. Takane, 1996, Functional analysis of the human androgen receptor promoter., Mol Cell Endocrinol, 119, 83, 10.1016/0303-7207(96)03800-2 · DOI
  60. Ren, 2000, Tea polyphenols down regulate the expression of the androgen receptor in LNCaP prostate cancer cells., Oncogene, 19, 1924, 10.1038/sj.onc.1203511 · DOI
  61. Mizokami, 1994, Identification of 3′,5′-cyclic adenosine monophosphate response element and other cis acting elements in the human androgen receptor gene promoter., Mol Endocrinol, 8, 77
  62. Roeder, 1996, The role of general initiation factors in transcription by RNA polymerase II., Trends Biochem Sci, 21, 327, 10.1016/0968-0004(96)10050-5 · DOI · Paper page
  63. Pugh, 1991, Transcription from a TATA-less promoter requires a multisubunit TFIID complex., Gene Dev, 5, 1935, 10.1101/gad.5.11.1935 · DOI · Paper page
  64. Faber, 1991, Characterization of the human androgen receptor transcription unit., J Biol Chem, 266, 10743, 10.1016/S0021-9258(18)99080-0 · DOI
  65. Tilley, 1990, Expression of the human androgen receptor gene utilizes a common promoter in diverse human tissues and cell lines., J Biol Chem, 265, 13776, 10.1016/S0021-9258(18)77416-4 · DOI
  66. Faber, 1993, Two different, overlapping pathways of transcription initiation are active on the TATA-less human androgen promoter: the role of Sp1., J Biol Chem, 268, 9296, 10.1016/S0021-9258(18)98349-3 · DOI
  67. Chen, 1997, Functional role of a conformationally flexible homopurine/homopyrimidine domain of the androgen receptor gene promoter interacting with SP1 and a pyrimidine single strand binding protein., Mol Endocrinol, 11, 3, 10.1210/mend.11.1.9868 · DOI
  68. Lindzey, 1993, Regulation of the 5′-flanking region of the mouse androgen receptor gene by cAMP and androgen., Mol Endocrinol, 7, 1530
  69. Blok, 1992, Transcriptional regulation of androgen receptor gene expression in Sertoli cells and other cell types., Mol Cell Endocrinol, 88, 153, 10.1016/0303-7207(92)90020-7 · DOI
  70. Blok, 1992, Transient down-regulation of androgen receptor messenger ribonucleic acid (mRNA) expression in Sertoli cells by follicle-stimulating hormone is followed by up-regulation of androgen receptor mRNA and protein., Endocrinology, 131, 1343, 10.1210/endo.131.3.1324158 · doi:10.1210/endo.131.3.1324158
  71. Song, 1999, Negative regulation of the androgen receptor gene promoter by NF1 and an adjacently located multiprotein-binding site., Mol Endocrinol, 13, 1487, 10.1210/mend.13.9.0350 · DOI
  72. Supakar, 1993, A novel regulatory element associated with age-dependent expression of the rat androgen receptor gene., J Biol Chem, 268, 26400, 10.1016/S0021-9258(19)74328-2 · DOI
  73. Supakar, 1995, Nuclear factor κB functions as a negative regulator for the rat androgen receptor gene and NF-κB activity increases during the age-dependent desensitization of the liver., J Biol Chem, 270, 837, 10.1074/jbc.270.2.837 · DOI
  74. Jarrard, 1998, Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells., Cancer Res, 58, 5310
  75. Esteller, 2001, A gene hypermethylation profile of human cancer., Cancer Res, 61, 97
  76. Sasaki, 2000, The expansion of the CAG repeat in exon 1 of the human androgen receptor gene is associated with uterine endometrial carcinoma., Mol Carcinog, 27, 237, 10.1002/(SICI)1098-2744(200003)27:3<237::AID-MC11>3.0.CO;2-0 · doi:10.1002/(sici)1098-2744(200003)27:3<237::aid-mc11>3.0.co;2-0
  77. Kinoshita, 2000, Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer., Cancer Res, 60, 3623
  78. Brandeis, 1994, Sp1 elements protect a CpG island from de novo methylation., Nature, 371, 435, 10.1038/371435a0 · DOI · Paper page
  79. Macleod, 1994, Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island., Genes Dev, 8, 2282, 10.1101/gad.8.19.2282 · DOI · Paper page
  80. Yeap, 1999, Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells., Endocrinology, 140, 3282, 10.1210/endo.140.7.6769 · DOI
  81. Mizokami, 1994, Induction of translation by the 5′-untranslated region of human androgen receptor mRNA., J Biol Chem, 269, 25655, 10.1016/S0021-9258(18)47299-7 · DOI
  82. Faber, 1991, The interaction of ubiquitous DNA-binding factors, availability of binding sites in the chromatin, and DNA methylation in the differential regulation of phosphoenol pyruvate carboxykinasse gene expression., Nucleic Acids Res, 19, 4681, 10.1093/nar/19.17.4681 · DOI
  83. Yeap, 2002, Novel binding of HuR and poly(C)-binding protein to a conserved UC-rich motif within the 3′-untranslated region of the androgen receptor messenger RNA., J Biol Chem, 277, 27183, 10.1074/jbc.M202883200 · DOI
  84. Peng, 1998, RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein., EMBO J, 17, 3461, 10.1093/emboj/17.12.3461 · DOI · Paper page
  85. Chkheidze, 1999, Assembly of the β-globin mRNA stability complex reflects binary interaction between the pyrimidine-rich 3′ untranslated region determinant and poly(C) binding protein CP., Mol Cell Biol, 19, 4572, 10.1128/MCB.19.7.4572 · DOI
  86. Ostareck, 1997, mRNA silencing in erythroid differentiation: hnRNP K and hnRNP E1 regulate 15-lipoxygenase translation from the 3′ end., Cell, 89, 597, 10.1016/S0092-8674(00)80241-X · DOI · Paper page
  87. Hellwinkel, 2001, A unique exonic splicing mutation in the human androgen receptor gene indicates a physiologic relevance of regular androgen receptor transcript variants., J Clin Endocrinol Metab, 86, 2569
  88. Lee, 1998, Proteasome inhibitors: valuable new tools for cell biologists., Trends Cell Biol, 8, 397, 10.1016/S0962-8924(98)01346-4 · DOI · Paper page
  89. Hershko, 1998, The ubiquitin system., Annu Rev Biochem, 67, 425, 10.1146/annurev.biochem.67.1.425 · DOI · Paper page
  90. Alarid, 1999, Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation., Mol Endocrinol, 13, 1522, 10.1210/mend.13.9.0337 · doi:10.1210/mend.13.9.0337 · Paper page
  91. El-Khissiin, 1999, Implication of proteasome in estrogen receptor degradation., FEBS Lett, 448, 160, 10.1016/S0014-5793(99)00343-9 · DOI
  92. Lonard, 2000, The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor transcription., Mol Cell, 5, 939, 10.1016/S1097-2765(00)80259-2 · DOI · Paper page
  93. Lange, 2000, Phosphorylation of human progesterone receptors a serine 294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome., Proc Natl Acad Sci USA, 97, 132, 10.1073/pnas.97.3.1032 · DOI · Paper page
  94. Tyagi, 2000, Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells., Mol Endocrinol, 14, 1162, 10.1210/mend.14.8.0497 · DOI · Paper page
  95. Gregory, 2001, Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen., Cancer Res, 61, 2892
  96. Koepp, 2001, Phosphorylation-dependent ubiquitination of cyclin E by SCFFbw7 ubiquitin ligase., Science, 294, 173, 10.1126/science.1065203 · DOI · Paper page
  97. Brown, 1995, Control of I kappa B-alpha proteolysis by site specific, signal induced phophorylation., Science, 267, 1485, 10.1126/science.7878466 · DOI · Paper page
  98. Brockman, 1995, Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation., Mol Cell Biol, 15, 2809, 10.1128/MCB.15.5.2809 · DOI · Paper page
  99. Lin, 2002, Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase., EMBO J, 21, 4037, 10.1093/emboj/cdf406 · DOI · Paper page
  100. Wen, 2000, Her2/neu promotes androgen independent survival and growth of prostate cancer cells through the Akt pathway., Cancer Res, 60, 6841
  101. Lin, 1998, Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines., J Biol Chem, 273, 5939, 10.1074/jbc.273.10.5939 · doi:10.1074/jbc.273.10.5939
  102. Merry, 2001, Molecular pathogenesis of spinal and bulba muscular atrophy., Brain Res Bull, 56, 203, 10.1016/S0361-9230(01)00594-9 · DOI
  103. Abdullah, 1998, Spinobulbar muscular atrophy: polyglutamine-expanded androgen receptor is proteolitically resistant in vitro and processed abnormally in transfected cells, Hum Mol Genet, 7, 379, 10.1093/hmg/7.3.379 · DOI
  104. Butler, 1998, Truncated forms of the androgen receptor are associated with polyglutamine expansion in X-linked spinal and bulbar muscular atrophy., Hum Mol Genet, 7, 121, 10.1093/hmg/7.1.121 · DOI
  105. Kahlem, 1996, Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking., Proc Natl Acad Sci USA, 93, 14580, 10.1073/pnas.93.25.14580 · DOI · Paper page
  106. Bailey, 2002, Molecular chaperones enhances the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulba muscular atrophy., Hum Mol Genet, 11, 515, 10.1093/hmg/11.5.515 · DOI · Paper page
  107. Ellerby, 1999, Kennedy’s disease: caspase cleavage of the androgen receptor is a critical event in cytotoxicity., J Neurochem, 72, 185, 10.1046/j.1471-4159.1999.0720185.x · DOI · Paper page
  108. Katsuno, 2002, Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy., Neuron, 35, 843, 10.1016/S0896-6273(02)00834-6 · DOI · Paper page
  109. Jemal, 2003, Cancer statistics., CA Cancer J Clin, 53, 5, 10.3322/canjclin.53.1.5 · DOI · Paper page
  110. Huggins, 1943, Studies on prostate cancer., Arch Surg, 43, 209, 10.1001/archsurg.1941.01210140043004 · DOI · Paper page
  111. Taplin, 1995, Mutation of the androgen receptor gene in metastatic androgen-independent prostate cancer., N Engl J Med, 332, 1393, 10.1056/NEJM199505253322101 · DOI · Paper page
  112. Miyamoto, 1998, Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate DU145 cells., Proc Natl Acad Sci USA, 95, 7379, 10.1073/pnas.95.13.7379 · DOI · Paper page
  113. McDonnell, 1992, Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer., Cancer Res, 52, 6940
  114. Raffo, 1995, Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen deprivation in vivo., Cancer Res, 55, 4438
  115. Lipponen, 1997, Expression of the apoptosis suppressing protein bcl-2 in prostatic adenocarcinoma is related to tumor malignancy., Prostate, 32, 9, 10.1002/(SICI)1097-0045(19970615)32:1<9::AID-PROS2>3.0.CO;2-I · doi:10.1002/(sici)1097-0045(19970615)32:1<9::aid-pros2>3.0.co;2-i
  116. Aaltomaa, 1999, Prognostic value and expression of p21 protein in prostate cancer., Prostate, 39, 8, 10.1002/(SICI)1097-0045(19990401)39:1<8::AID-PROS2>3.0.CO;2-N · DOI
  117. Kuiper, 1989, Structural organization of the human androgen receptor gene, J Mol Endocrinol, 2, R2, 10.1677/jme.0.002R001 · DOI · Paper page
  118. Lubahn, 1989, Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity., Proc Natl Acad Sci USA, 86, 9534, 10.1073/pnas.86.23.9534 · DOI · Paper page
  119. Linja, 2001, Amplification and overexpression of androgen receptor gene in hormone refractory prostate cancer., Cancer Res, 61, 3550
  120. Miyoshi, 2000, Fluorescence in situ hybridization evaluation of c-myc and androgen receptor gene amplification and chromosomal anomalies in prostate cancer in Japanese patients., Prostate, 43, 225, 10.1002/(SICI)1097-0045(20000515)43:3<225::AID-PROS9>3.0.CO;2-7 · doi:10.1002/(sici)1097-0045(20000515)43:3<225::aid-pros9>3.0.co;2-7
  121. Bubendorf, 1999, Survey of gene amplifications during prostate cancer progression by high throughput fluorescence in situ hybridization on tissue microarrays., Cancer Res, 59, 803
  122. Edwards, 2001, Amplification of the androgen receptor may not explain the development of androgen independent prostate cancer., Br J Urol Int, 88, 633, 10.1046/j.1464-410X.2001.02350.x · DOI
  123. Gottlieb, 2001, Variable expressivity and mutation databases: the androgen receptor gene mutations database., Hum Mutat, 17, 382, 10.1002/humu.1113 · DOI
  124. Marcelli, 2000, Androgen receptor mutations in prostate cancer., Cancer Res, 60, 944
  125. Culig, 1993, Mutant androgen receptor detected in an advanced stage prostatic carcinoma is activated by adrenal androgens and progesterone., Mol Endocrinol, 7, 1541
  126. Zhao, 2000, Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor., Nat Med, 6, 703, 10.1038/76287 · DOI · Paper page
  127. Lee, 1995, Regulation of proliferation and production of PSA in androgen-sensitive prostate cancer cells, LNCaP, by DHT., Endocrinology, 136, 796, 10.1210/endo.136.2.7530653 · doi:10.1210/endo.136.2.7530653 · Paper page
  128. Yuan, 1993, Androgen-induced inhibition of cell proliferation in an androgen insensitive prostate cancer cell line (PC-3) transfected with a human androgen receptor complimentary DNA., Cancer Res, 53, 13004
  129. Zhang, 2002, Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells., Proc Natl Acad Sci USA, 99, 7408, 10.1073/pnas.102014399 · DOI
  130. Mitchell, 1999, Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells., Cancer Res, 59, 5892

Cited by

See all 183

Metadata

Authors
Lee, D. K., & Chang, C.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2003-09-01
Volume
88
Issue
9
Pages
4043-4054
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2092714565
Cited by
183
References
14
FWCI
6.00
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.